Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity
June 27, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, June 26, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and...
DriveThru Urgent Care launches game-changing approach to help patients get better faster
June 20, 2023 11:35 ET
|
Viral Solutions LLC
ATLANTA, June 20, 2023 (GLOBE NEWSWIRE) -- This summer, DriveThru Urgent Care — by Viral Solutions — will usher in a groundbreaking era of healthcare by treating patients with time-sensitive medical...
HLA Testing Market - 7.5% CAGR for Human Leukocyte Antigen Testing Market Size Worth $1.15 Billion, Globally, by 2028 – The Insight Partners
June 19, 2023 09:21 ET
|
The Insight Partners
Pune, India, June 19, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Human Leukocyte Antigen (HLA) Testing Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by...
Vielight Inc. Receives Health Canada Approval for Treatment of Covid-19 with Near Infrared Device Technology
June 14, 2023 16:13 ET
|
Vielight Inc.
Toronto, Canada, June 14, 2023 (GLOBE NEWSWIRE) -- Update to Release on Globe Newswire from May 25, 2023 13:30 ET Vielight announced on Thursday, May 25, 2023 that its Vielight RX Plus device -...
mRNA Vaccines and Therapeutics Market Size is projected to reach USD 58.92 billion by 2031, growing at a CAGR of 13.3%: Straits Research
June 08, 2023 11:00 ET
|
Straits Research
New York, United States, June 08, 2023 (GLOBE NEWSWIRE) -- mRNA-based therapeutics and vaccines permit the combination of desirable immunological properties. These are manufactured in the laboratory...
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting
June 02, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, 2 June 2023. Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus” or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral,...
GeoVax Partners With ABL to Advance cGMP Production of Vaccine Candidates
May 31, 2023 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, May 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious...
Kinarus Therapeutics Group Reports 2022 Annual Results
May 31, 2023 01:00 ET
|
Kinarus Therapeutic Holding AG
Publishes Annual Report with Audited Consolidated Financial Results for Year Ended 31 December 2022Clinical efforts re-focused on developing KIN001 for original indications IPF and wet AMDCDIM CHF1.5...
Results of Study on COVID-19 Vaccine Response in Hematopoietic Cell Transplant Patients Published in eClinicalMedicine
May 24, 2023 11:28 ET
|
Be The Match
MINNEAPOLIS, May 24, 2023 (GLOBE NEWSWIRE) -- Results from a joint study between CIBMTR® (Center for International Blood and Marrow Transplant Research®)—a research collaboration between the...
AIM ImmunoTech Reports First Quarter Financial Results and Provides Pipeline Update
May 15, 2023 08:45 ET
|
AIM ImmunoTech Inc.
– Continued execution across pipeline positions AIM to achieve multiple clinical and regulatory value-driving milestones throughout 2023– Lead clinical program, Phase 2 locally advance pancreatic...